BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: Implications for melanoma staging and adjuvant therapy-Reference-Cited by-同舟云学术

BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: Implications for melanoma staging and adjuvant therapy

Published:2014-10 Issue:15 Volume:50 Page:2668-2676
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Barbour Andrew P.,Tang Yue Hang,Armour Nicola,Dutton-Regester Ken,Krause Lutz,Loffler Kelly A.,Lambie Duncan,Burmeister Bryan,Thomas Janine,Smithers B. Mark,Hayward Nicholas K.

Funder

Princess Alexandra Hospital Foundation

National Health & Medical Research Council

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference42 articles.

1. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases;Calabro;Arch Surg,1989

2. Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis;Coit;Ann Surg,1991

3. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy;Lee;Int J Radiat Oncol Biol Phys,2000

4. Final version of 2009 AJCC melanoma staging and classification;Balch;J Clin Oncol,2009

5. Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis;Mocellin;J Natl Cancer Inst,2010

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant Therapy Using Dabrafenib plus Trametinib in Chinese Patients with Resected Stage III Melanoma: A Multicenter Retrospective Cohort Study;Dermatologic Therapy;2024-05-24

2. Corresponding ctDNA and tumor burden dynamics in metastatic melanoma patients on systemic treatment;Translational Oncology;2024-04

3. Predicting the BRAF mutation with pretreatment MRI radiomics features for melanoma brain metastases receiving Gamma Knife radiosurgery;Clinical Radiology;2023-12

4. BRAF variant allele fraction—A predictor of response to targeted therapy?;Journal of the European Academy of Dermatology and Venereology;2023-09-25

5. Improved Sensitivity in BRAFV600E Detection in Combined Tissue and Extracellular Vesicle-Based Liquid Biopsy in Melanoma;Journal of Investigative Dermatology;2023-08